No Data
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersElutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions (
NextCure Faces Court Review of Reverse Stock Split
NextCure Ends Beltsville Lease to Cut Operating Costs
Major Former Stakeholder Makes a Significant Move in NextCure Stock
Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)
Insider Sale: Insider at $NXTC Sells 30,000 Shares
Zaiming, Inc. Simcere, an insider at $NXTC, sold 30,000 shares of the company on 08-10-2026 for an estimated $184,800. We received data on the trade from a recent SEC filing. This was a sale of
Tonyco : be cautious. pre- revenue biotechs are dilution machines, meaning they're gonna need to issue shares to keep running
without digging too deeply, these guys have about 6 month runway , eating approximately 40M a year (q1 was -10, q2 was -10), and cash at $15M.
looks like theyre about to dilute again in Q4.
Positive news was good for them, but their product is only in phase 1.
It takes 1-2yr for P1 to P2. 1-2yr for P2 to P3 and 2-3yr for P3. after they file a NDA or are close is when to buy.
finally, a share:
$Nanoviricides (NNVC.US)$ are one ive been watching for years. Once they finally get close to release they will be revolutionary: a broad-spectrum treatment for viruses. fucking cool man.